Table 4 Antimicrobial susceptibility of S. flexneri clinical isolates
Antimicrobial agents | S. flexneri clinical isolates | |||
|---|---|---|---|---|
S | I | SDD | R | |
Penicillins | ||||
Ampicillin | 1 (1%) | 0 (0%) | – | 96 (99%) |
Cephems | ||||
Cefotaxime | 49 (50.5%) | 2 (2.1%) | – | 46 (47.4%) |
Cefepime | 55 (56.7) | – | 9 (9.3%) | 33 (34%) |
Folate pathway antagonists | ||||
Trimethoprim-sulfamethoxazole | 5 (5.2%) | 5 (5.2%) | – | 87 (89.7%) |
Macrolides | ||||
Azithromycin | 87 (89.7%) | 1 (1%) | – | 9 (%9.3) |
Quinolones and fluoroquinolones | ||||
Ciprofloxacin | 87 (89.7%) | 3 (3.1%) | – | 7 (7.2%) |
Nalidixic acid | 46 (47.4%) | 21 (21.6%) | – | 30 (30.9%) |
Tetracyclines | ||||
Minocycline | 51 (52.6%) | 18 (18.6%) | – | 28 (28.9%) |